ReviewMikrochimica acta2026
Research progress on nanoplatforms for in vivo miRNA detection over the past decade.
Review in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Accurate in vivo microRNA (miRNA) detection is of great significance for disease diagnosis and therapy, but traditional methods face limitations in terms of sensitivity, penetration depth, and dynamic monitoring capabilities. Nanomaterial-based detection technologies provide innovative analytical platforms to overcome these challenges. This review systematically summarizes the research progress on in vivo miRNA detection technologies over the past decade, covering fluorescence detection, near-infrared imaging, magnetic resonance imaging, and multimodal composite detection platform design strategies and performance. The review also analyzes the applications and technical advantages of each method. Finally, the challenges and opportunities in developing these detection platforms are discussed, providing a reference for further research and clinical application of in vivo miRNA detection technologies.
Indexed as
Identifiers
42698035What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.